Medline Sterile Reprocessing

Stony Brook University Hospital is procuring Medline Sterile Reprocessing Products through a contract awarded by Premier, a consortium entity authorized under New York State Finance Law section 163(3)(vi). This procurement involves the purchase of sterile reprocessing products, with the initial contract term spanning two years from November 1, 2025, through January 31, 2028, followed by three optional one-year renewal periods contingent upon the Group Purchasing Organization's renewal or extension. Vendors offering equivalent Medline Sterile Reprocessing Products are invited to contact the designated procurement officer to discuss participation. All proposals must be submitted by close of business on November 25, 2025. Successful contractors will be required to complete vendor responsibility documentation, comply with NYS Finance Law 139 (lobbying law), submit NYS Tax Law Section 5-a certifications, and provide valid and current New York Workers' Compensation and Disability Forms. Vendors must exercise caution regarding contact restrictions under the lobbying law, as unauthorized communications can result in contract denial or debarment from sales to any New York State agency.

No set-aside designations or minority/women business enterprise (MWBE) contracting goals have been established for this procurement, with both MBE and WBE goals set at 0.00 percent. There are no listed incumbent vendors or existing contractors identified as currently holding similar contracts. The procurement documentation indicates that no business enterprises have been awarded identical or substantially similar contracts within the past five years. No specific award value or budget range is disclosed in the available procurement materials. This opportunity is available to all qualified vendors capable of supplying the specified Medline Sterile Reprocessing Products and meeting the applicable compliance and documentation requirements.